Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis

BACKGROUND: When target glycated hemoglobin (HbA(1c)) levels are not reached, basal insulin therapy should be considered in type 2 diabetes. The objective of this report was to describe the predictors of glycemic control (strict criterion: HbA(1c) ≤6.5%) during the first year after initiating basal...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostev, Karel, Dippel, Franz W, Rathmann, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298311/
https://www.ncbi.nlm.nih.gov/pubmed/25609990
http://dx.doi.org/10.2147/DMSO.S76855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298311/
https://www.ncbi.nlm.nih.gov/pubmed/25609990
http://dx.doi.org/10.2147/DMSO.S76855

Ejemplares similares